MIFLONIDE Breezhaler caps inh 400 mcg 60 pce

7680551300045 CH-55130 R03BA02
MIFLONIDE Breezhaler caps inh 400 mcg 60 pce
MIFLONIDE Breezhaler caps inh 400 mcg 60 pce
MIFLONIDE Breezhaler caps inh 400 mcg 60 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Articles (1)

Miflonide Breezhaler 400 mcg, Hartkapseln mit Pulver zur Inhalation
Pulver
60
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
budesonidum
400.0 UG Substance Wirkstoff (Principe actif)
lactosum monohydricum
- Substance HNIDK

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
55130
Drug name
Miflonide Breezhaler, Hartkapseln mit Pulver zur Inhalation
Galenic form
KAHI
ATC Code
R03BA02
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
30/05/2000
Authorization expiration date
02/10/2025
IT number
03.04.4.
Domain
Human medicine
Field of application
Obstruktive Atemwegserkrankungen

Packaging details

Description (FR)
MIFLONIDE Breezhaler caps inh 400 mcg 60 pce
Description (DE)
MIFLONIDE Breezhaler Inh Kaps 400 mcg 60 Stk
Market launch
30/05/2000
Market withdrawal
02/10/2025
Narcotic (BTM)
No

Other packaging sizes

MIFLONIDE Breezhaler caps inh 200 mcg 60 pce
60 KAP
View
Buy us a coffee Explore the data